Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 15, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,159	3,440	2,717	1,641	502	1,314
Market Cap Growth	109.56%	26.64%	65.56%	227.08%	-61.83%	30.31%
Enterprise Value	6,891	3,397	2,419	1,295	176	1,116
Last Close Price	113.34	55.98	45.97	29.12	9.98	29.73
PS Ratio	41.39	26.44	35.09	69.42	159.06	-
PB Ratio	50.79	20.91	16.00	6.21	1.77	7.89
P/TBV Ratio	50.21	221.17	16.69	6.40	1.80	7.89
EV/Sales Ratio	39.53	26.10	31.24	54.79	55.81	-
Debt / Equity Ratio	0.38	0.69	0.63	0.29	0.01	0.02
Asset Turnover	0.40	0.36	0.22	0.07	0.01	-
Inventory Turnover	1.03	0.98	1.61	1.41	-	-
Quick Ratio	4.31	2.94	5.27	8.53	6.81	9.60
Current Ratio	4.75	3.24	5.58	8.90	7.10	10.10
Return on Equity (ROE)	-85.79%	-155.91%	-85.10%	-66.05%	-30.89%	-59.88%
Return on Assets (ROA)	-26.74%	-45.77%	-32.22%	-31.45%	-41.15%	-34.45%
Return on Capital (ROIC)	-34.49%	-59.75%	-37.22%	-35.62%	-46.59%	-37.59%
Return on Capital Employed (ROCE)	-46.30%	-95.90%	-66.40%	-52.30%	-59.40%	-80.80%
Earnings Yield	-2.75%	-7.58%	-6.80%	-11.04%	-13.88%	-10.20%
FCF Yield	-1.52%	-3.31%	-5.01%	-10.59%	-29.19%	-9.30%
Buyback Yield / Dilution	-5.39%	-5.76%	-10.65%	-5.08%	-12.40%	-21.15%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q